Education
About Us
Working with TipRanks
Follow Us
Vaccinex Inc (VCNX)
OTHER OTC:VCNX
Avelumab And Pepinemab
Metastatic Pancreatic Adenocarcinoma
Phase I/II
Active Not Recruiting
Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma
Oct 21, 2021
―
Pepinemab + Pembrolizumab
Recurrent/Metastatic Squamous Cell Carcinoma Of The Head And Neck (Hnscc)
Phase I/II
Completed
Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Mar 22, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vaccinex Inc (VCNX) have in its pipeline
VCNX is currently developing the following drugs: Avelumab And Pepinemab, Pepinemab + Pembrolizumab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.